Evidence map›Paper›PMID 41256670›Full record

ArticlebioRxiv : the preprint server for biology2025

Clinically observed

Maxum E Paul, Rediet B Delelegne, Jocelyn E Chau, Titus J Boggon

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Maxum E PaulDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA 06520.ORCID 0000-0001-5551-1893
Rediet B DelelegneDepartment of Pharmacology, Yale University, New Haven, CT, USA 06510.ORCID 0009-0006-3220-4595
Jocelyn E ChauDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA 06520.ORCID 0000-0001-8623-3347
Titus J BoggonDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA 06520.ORCID 0000-0003-2862-1637

Funding

INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARDT32GM007324 · NIGMS · YALE UNIVERSITY · PI BENNETT, ANTON M · 1987 to 2022
$6.2M
Human Genetics and Molecular Mechanisms of Vein of Galen Aneurysmal MalformationR01NS117609 · NINDS · YALE UNIVERSITY · PI Titus Jonathon Boggon, Kristopher T. Kahle · 2020 to 2026
$3.3M
Inter-Domain Regulation of p120RasGAPF31HL167578 · NHLBI · YALE UNIVERSITY · PI PAUL, MAXUM · 2023 to 2025
$146k
NHLBI NIH HHS F31 HL167578NIGMS NIH HHS T32 GM007324NINDS NIH HHS R01 NS117609
6 · The paper itself

Abstract

The

Indexed as

cancerCM-AVMGTPase activating proteinGTP hydrolysisp120RasGAPRASA1Ras signalingvein of Galen malformation

Identifiers

PMID41256670
PMCPMC12621883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.